Predictmedix AI Inc. is a listed company. Its insiders report their share dealings to SEDI. 2 insiders have disclosed 2 filings since 24 October 2025.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
Over the last twelve months, not one insider purchase of Predictmedix AI Inc. stock was filed.
For context, the typical company on the same exchange (median of 2,734 companies) published 14 filings over the same period, against 2 filings here.
These figures are compiled from regulatory filings published by SEDI. They describe what insiders did and are not a recommendation.
This score ranks the purchase within its own market. A position size is suggested only on the venues of the backtested strategy universe; elsewhere, signals stay on watch. Not investment advice.
· cache
2 of 2 declarations
Predictmedix AI Inc. is a company focused on developing artificial intelligence solutions for the healthcare sector. It aims to enhance diagnostics and care through innovative technologies.